2024-09-01 2025-08-31 2025-08-31 false 12810986 HAYESGATE OSTEOPATHY LIMITED 86220 Specialists medical practice activities iso4217:GBP xbrli:pure 12810986 2024-09-01 12810986 2025-08-31 12810986 2024-09-01 2025-08-31 12810986 bus:Micro-entities 2024-09-01 2025-08-31 12810986 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 12810986 bus:FullAccounts 2024-09-01 2025-08-31 12810986 core:WithinOneYear 2025-08-31 12810986 core:AfterOneYear 2025-08-31 12810986 core:WithinOneYear 2024-09-01 2025-08-31 12810986 core:AfterOneYear 2024-09-01 2025-08-31 12810986 core:CurrentFinancialInstruments 2025-08-31 12810986 core:Non-currentFinancialInstruments 2025-08-31 12810986 core:CurrentFinancialInstruments 2024-09-01 2025-08-31 12810986 core:Non-currentFinancialInstruments 2024-09-01 2025-08-31 12810986 core:LandBuildings 2024-09-01 2025-08-31 12810986 core:FurnitureFittings 2024-09-01 2025-08-31 12810986 core:OfficeEquipment 2024-09-01 2025-08-31 12810986 core:Vehicles 2024-09-01 2025-08-31 12810986 core:PlantMachinery 2024-09-01 2025-08-31 12810986 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 12810986 core:LandBuildings 2025-08-31 12810986 core:PlantMachinery 2025-08-31 12810986 core:Vehicles 2025-08-31 12810986 core:FurnitureFittings 2025-08-31 12810986 core:OfficeEquipment 2025-08-31 12810986 core:OtherPropertyPlantEquipment 2025-08-31 12810986 core:Right-of-useAssets 2024-09-01 2025-08-31 12810986 core:Right-of-useAssets 2025-08-31 12810986 core:Goodwill 2024-09-01 2025-08-31 12810986 core:PatentsTrademarksLicencesConcessionsSimilar 2024-09-01 2025-08-31 12810986 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-09-01 2025-08-31 12810986 core:OtherResidualIntangibleAssets 2024-09-01 2025-08-31 12810986 core:Goodwill 2025-08-31 12810986 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-08-31 12810986 core:PatentsTrademarksLicencesConcessionsSimilar 2025-08-31 12810986 core:OtherResidualIntangibleAssets 2025-08-31 12810986 dpl:CostSales 2024-09-01 2025-08-31 12810986 dpl:AdministrativeExpenses 2024-09-01 2025-08-31 12810986 dpl:DistributionCosts 2024-09-01 2025-08-31 12810986 2023-09-01 12810986 2024-08-31 12810986 2023-09-01 2024-08-31 12810986 core:WithinOneYear 2024-08-31 12810986 core:AfterOneYear 2024-08-31 12810986 core:CurrentFinancialInstruments 2024-08-31 12810986 core:Non-currentFinancialInstruments 2024-08-31 12810986 core:LandBuildings 2024-08-31 12810986 core:PlantMachinery 2024-08-31 12810986 core:Vehicles 2024-08-31 12810986 core:FurnitureFittings 2024-08-31 12810986 core:OfficeEquipment 2024-08-31 12810986 core:OtherPropertyPlantEquipment 2024-08-31 12810986 core:Right-of-useAssets 2024-08-31 12810986 core:Goodwill 2024-08-31 12810986 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-08-31 12810986 core:PatentsTrademarksLicencesConcessionsSimilar 2024-08-31 12810986 core:OtherResidualIntangibleAssets 2024-08-31 12810986 dpl:AdministrativeExpenses 2023-09-01 2024-08-31 12810986 bus:Director1 2024-09-01 2025-08-31 12810986 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31
HAYESGATE OSTEOPATHY LIMITED
Unaudited Financial Statements
for the year ended 31 August 2025
Company registration number 12810986
(England and Wales)

# Company Information

For the year ended 31 August 2025

Director | Boddy, Martin

Company secretary | Boddy, Jennifer Ann

Registered office | Cornerstone House 1 Manor Chase
| Undy
| Caldicot
| NP26 3PA

Registered number | 12810986

Accountant | Cornerstone Accounting Services

# Statement of Financial Position

As at 31 August 2025

2025
2024
£
£
£
£
Fixed assets
2,042
2,946
Current assets
722
857
Creditors amounts falling due within one year
(2,840)
(3,112)
Net current assets (liabilities)
(2,118)
(2,255)
Total assets less current liabilities
(76)
691
Accruals and deferred income
(586)
(550)
Net assets (liabilities)
(662)
141
Capital and reserves
(662)
141

# Notes to the Financial Statements

### 1. Employees

The average number of employees during the year was 1 (2024: 0).
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the Board of Directors on 15 May 2026 and are signed on its behalf by:

Boddy, Martin Boddy, Martin Director |

Company registration number 12810986